Form 4: AbbVie Director Jennifer L. Davis Reports Acquisition of Restricted Stock Units

Director Jennifer L. Davis reports acquisition of 1,203 restricted stock units in AbbVie Inc.

Summary

• On May 9, 2025, Jennifer L. Davis, a director of AbbVie Inc., acquired 1,203 restricted stock units (RSUs) under the AbbVie Amended and Restated 2013 Incentive Stock Program.
• These RSUs will be paid out in shares of AbbVie common stock on a one-to-one basis upon the earlier of the director's separation from service, death, or a change in control as defined in the Program.
• Following the transaction, Davis directly owns 2,525 shares of AbbVie common stock.

Sentiment

Score: 5

Explanation: This is a neutral report on a standard transaction. It doesn't inherently indicate positive or negative sentiment.

Future Outlook

The restricted stock units will be paid out in shares of AbbVie common stock upon the occurrence of certain events in the future.

Industry Context

Form 4 filings are standard disclosures required by the SEC for insiders of publicly traded companies, providing transparency into their transactions in the company's securities.

Stakeholder Impact

• The acquisition of restricted stock units by a director aligns the director's interests with those of the shareholders.

Key Dates

Keywords

Form 4, AbbVie, Director, RSU, Jennifer L. Davis, Beneficial Ownership, Incentive Stock Program, ABBV